Mohammad Khan Enlisted for Sensus Healthcare’s Medical Advisory Board

Sensus Healthcare Inc. has welcomed Mohammad K. Khan, M.D., Ph.D., to its Medical Advisory Board.

“I am honored to be named to the Medical Advisory Board for Sensus Healthcare and am glad that we have a portable device to treat skin cancer,” said Dr. Khan. “This makes it far easier to treat patients closer to home. I look forward to helping further advance SRT for the treatment of non-melanoma skin cancer.”

Dr. Khan’s appointment increases the size of the Sensus Medical Advisory Board to 10 professionals.
 
Dr. Khan is a world-renowned physician scientist who is currently a professor of Medicine in the Department of Radiation Oncology at Emory University School of Medicine. As a board-certified radiation oncologist specializing in leukemia, lymphoma, melanoma, skin cancer (basal, squamous and Merkel cell), multiple myeloma and pediatric cancers, he treats patients at Winship Cancer Institute of Emory University. In addition to numerous administrative appointments, Dr. Khan is Research Associate Professor of Engineering in the Department of Nuclear Engineering at the University of Tennessee, Knoxville, associate professor in the Department of Nuclear Engineering at the Georgia Institute of Technology, a staff radiation oncologist at Children’s Hospital of Atlanta, and chief of Lymphoma, Myeloma, Hematology and Skin Service at Emory University.
 
Dr. Khan has authored hundreds of scientific abstracts and peer-reviewed articles, and has delivered poster presentations at conferences such as the annual meetings of the American College of Radiation Oncology (ACRO) and the American Society of Clinical Oncology (ASTRO), along with moderating programs at these and other professional radiation oncology meetings. He is the principal investigator in a Phase 3 study titled “Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (RESCUE1-19).”
 
Dr. han earned a bachelor of science degree in nuclear engineering and a bachelor of science degree in biology from the University of Tennessee, Knoxville, a master’s degree in nuclear engineering from the University of Tennessee, Knoxville, an M.D. from the University of Tennessee, Memphis, and a Ph.D. in nuclear engineering from the University of Tennessee, Knoxville. 

“We are delighted that a professional with Dr. Khan’s stature has agreed to serve on our Medical Advisory Board,” said Joe Sardano, chairman and CEO of Sensus Healthcare. “Although we are well-aware of his impressive work in treating skin cancers, along with research into low-dose radiation in COVID-19 patients, we are optimistic that Dr. Khan will provide important guidance regarding our Superficial Radiation Therapy and other dermatology applications as we continue to develop the marketplace for our products.”
 
Sensus Healthcare Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100, SRT-100+ and SRT-100 Vision systems. Its portfolio of medical device products include aesthetic lasers and a needleless TransDermal Infusion System.